NCT06066138 2026-03-11A Study of Therapeutic Drug Monitoring-Based Atezolizumab DosingNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting30 enrolled
NCT07297667 2026-02-13GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid TumoursCanadian Cancer Trials GroupPhase 1 Not yet recruiting30 enrolled
NCT02936102 2025-11-14A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.NovartisPhase 1 Terminated154 enrolled